摩根士丹利基金管理(中国)有限公司 |
Morgan Stanley Expansion Capital is a private investment platform targeting late-stage growth equity and credit investments in technology, healthcare, consumer, digital media and other high-growth sectors.
We specialize in making equity and credit investments in technology and other high-growth sectors, such as healthcare, digital media, e-commerce, consumer and business services. Our team predominantly invests in North America and Western Europe. Our focus is on late-stage private companies, largely with established products and services addressing established markets seeking capital to scale revenue and expand business operations.
In addition to capital, the team relies on its industry experience to drive strategic growth, improve board governance, optimize capital structures, enhance operational efficiency, recruit senior executives and advise on strategic and financial liquidity. We seek to leverage the Morgan Stanley global brand, insights, resources and relationships in all our investment activities.
Investments typically range from $15 million - $75 million per transaction but there may be additional size flexibility through syndicate and co-investor relationships. Morgan Stanley Expansion Capital typically leads investments, but will also co-lead and participate in syndicated opportunities.
We generally do not take controlling ownership positions, so our investment strategy is predicated upon a partnership framework with founders, management teams and fellow investors. Value creation is driven by growth with a particular focus on capital efficiency and demonstrated unit economics.
Expansion Capital’s Advisory Partners provide an additional resource across our investment portfolio. Advisory Partners often participate in the examination of investment opportunities, serve on company boards, share their market and business insights and consult with portfolio founders and management to drive growth throughout the life cycle of an investment.
Morgan Stanley Expansion Capital and its predecessors have invested in the growth sectors for over three decades. We believe we are unique in our ability to offer private equity or credit investment to late-stage growth companies with the flexibility to lead or syndicate investments. Our investment team and our portfolio companies benefit from Morgan Stanley's global resources, network and franchise. Our long tenure and unique relationship with Morgan Stanley affords our portfolio companies unparalleled access to thought leaders, industry experts, operational expertise and managerial talent. We believe that our experience and reputation enables us to build market leaders which are more valuable and better positioned, and thus able to drive outcomes which maximize exit value for our companies and our investors.
|
Phrasee revolutionizes customer experiences by optimizing the language brands use across the full customer journey. Its AI-powered SaaS platform brings together natural language generation, machine learning and dynamic optimization, making Phrasee the only provider of its kind to generate, optimize, automate, and analyze language in real time. Phrasee boosts customer engagement and increases lifetime value for the world's leading B2C brands – including Domino's, eBay, FARFETCH, Groupon, Party City and Walgreens – all while adhering to companies' unique brand standards and voice. Today, over 1 billion people across four continents have responded to Phrasee-generated language.
CompStak is the leading crowdsourced commercial real estate platform. They handle millions of data points each week to create a comprehensive, robust CRE datat set. CompStak envisions a commercial real estate industry in which accurate and transparent data leads to better, faster deals. CompStak is available on a subscription basis exclusively to qualified lenders, landlords, and investors operating in the commercial real estate space. A growing list of top tier banks, private equity funds, owner/operators, REITS, and advisors rely on CompStak.
Elligo Health Research ("Elligo"), a healthcare-enabling research organization powered by the novel IntElligo Research Stack technology, uses electronic health records and the trusted patient and physician relationship to ensure all patients have access to clinical research as a care option. Elligo directly engages physicians and patients who otherwise would not participate in clinical research and accelerate the development of new pharmaceutical, biotechnology, and medical device and diagnostic products.
ComplianceMetric ("CMX") is a tech startup that provides a platform to enable companies to gain control and transparency over their supply chains. Leading brands trust CMX's cloud-based Enterprise Quality Management Software (EQMS) CMX1 to help them achieve and maintain Operational and Quality Excellence. For over a decade, CMX has led the market with the most comprehensive, user-friendly, cloud-based EQMS platform for food and consumer brands. It’s the only enterprise solution to effectively combine supply chain quality and operational excellence into a single, fully configurable operating platform.
Elevate provides outsourced legal services to law firms and corporate legal departments in the United States and internationally. The Company was founded in 2011 and is headquartered in Los Angeles, California, with its consultants, lawyers, and technologists based in the United States, Canada, United Kingdom, Continental Europe, India, the Philippines, and Australia.
Neo4j, Inc. was founded in 2007 by Emil Eifrem and is based in San Mateo, California. In addition to its US presence, the company has a large technical development center based in Malmo, Sweden. The company pioneered the Graph Platform in the Database Management System (“DBMS”) software market. DBMS is software that enables enterprises to create, retrieve, update and manage distributed, unstructured and complex data in a real time manner. The Graph Platform offered by Neo4j enables solutions that are faster and require less code than traditional databases.
RocketLawyer is an online legal destination website for individuals and small businesses.
MotionPoint is a leading provider of website localization services to Fortune 1000 companies.
Founded in 2010 and headquartered in Marina Del Rey, CA, SmartyPants produces premium all-in-one multi-vitamins in a variety of formats for children and adults.
Provides life science tools and develops molecular diagnostics.
XSInc provides e-commerce and data management solutions for the life science and agricultural industries.
Plateau Systems is an enterprise learning management software platform. Acquired by Successfactors, acquired by SAP (NYSE:SAP).
Developer of therapeutic agents.
Perceptive Software provides document imaging and workflow software. Acquired by Lexmark International, Inc. (NYSE:LXK).
SPSS provides statistical data analysis software. (NASDAQ:SPSS), acquired by IBM (NYSE:IBM).
IDeaS provides revenue management software. Acquired by SAS Institute, Inc.
Provides laser technology to manufacture active optical components.
Avamar provides backup and restore software and systems. Acquired by EMC Corporation (NYSE:EMC).
Provides internet security management software and services. Acquired by British Telephone Group, (NYSE:BT).
Evolving Systems (NASDAQ:EVOL) is a telecom software solutions vendor.
Develops DEC VAX applications software.
Provides patient transportation services.
Business-to-business company focused on the design and construction market. Acquired by Autodesk.
Creates document and workflow management systems.
Provides IT services to middle-market/large enterprise customers.
Provides real estate information on the internet.
Provides image management software. Now ScanSoft (NASDAQ:SSFT).
Develops software applications for use in plant lifecycle management.
Enterprise Systems develops healthcare management software. Acquired by McKesson now McKessonHBOC, (NYSE:MCK).
Managed Health Network provides mental health management services. Acquired by FHS, now Health Net (NYSE:HNT).
Arcadian Management provides Medicare Advantage to underserved markets. Acquired by Humana (NYSE:HUM).
Provider of laser-programmable gate arrays.
Develops digital control technology for electric motors.
Strategy Name | Description |
---|---|
Makes privately negotiated later-stage investments in technology, health care, consumer, and other sectors.
|
Makes privately negotiated later-stage investments in technology, health care, consumer, and other sectors. |
As of 10/30/2021. Team and portfolio information may change from time to time.
There is no guarantee that any of the investments listed above resulted in positive performance (for realized holdings), or will perform well in the future (for current holdings). The trademarks and service marks above are the property of their respective owners. The information on this website has not been authorized, sponsored, or otherwise approved by such owners.
By clicking on any links shown here, you agree that you are navigating to a third party site. We are providing these hyperlinks to you only as a convenience and the inclusion of any hyperlink is not and does not imply any endorsement, approval, investigation, verification or monitoring by us of any information contained in any hyperlinked site. In no event shall we be responsible for the information contained on the site or your use of such site.
The information presented herein is solely for informational and educational purposes only. It is intended for the benefit of third party issuers and those seeking information about alternatives investment strategies. The information contained herein does not constitute and should not be construed as an offering of advisory services or an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction in which such offer or solicitation, purchase or sale would be unlawful under the securities, insurance or other laws of such jurisdiction.
The information presented does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy. The information herein has not been based on a consideration of any individual investor circumstances and is not investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To that end, investors should seek independent legal and financial advice, including advice as to tax consequences, before making any investment decision. There is no guarantee that any investment strategy will work under all market conditions, and each investor should evaluate their ability to invest for the long-term, especially during periods of downturn in the market.
Diversification does not protect you against a loss in a particular market; however it allows you to spread that risk across various asset classes. Past performance is no guarantee of future results.
Leveraging Morgan Stanley Resources - Subject to third party confidentiality agreement obligations and information barriers established by Morgan Stanley to manage potential conflicts of interest and applicable allocation policies.
Alternative investments are speculative and include a high degree of risk. Investors could lose all or a substantial amount of their investment. Alternative investments are suitable only for long-term investors willing to forego liquidity and put capital at risk for an indefinite period of time. Alternative investments are typically highly illiquid – there is no secondary market for private funds, and there may be restrictions on redemptions or assigning or otherwise transferring investments into private funds. Alternative investment funds often engage in leverage and other speculative practices that may increase volatility and risk of loss. Alternative investments typically have higher fees and expenses than other investment vehicles, and such fees and expenses will lower returns achieved by investors.
In the ordinary course of its business, Morgan Stanley engages in a broad spectrum of activities including, among others, financial advisory services, investment banking, asset management activities and sponsoring and managing private investment funds. In engaging in these activities, the interest of Morgan Stanley may conflict with the interests of clients.
Alternative investment funds are often unregulated, are not subject to the same regulatory requirements as mutual funds, and are not required to provide periodic pricing or valuation information to investors. The investment strategies described in the preceding pages may not be suitable for your specific circumstances; accordingly, you should consult your own tax, legal or other advisors, at both the outset of any transaction and on an ongoing basis, to determine such suitability.
No investment should be made without proper consideration of the risks and advice from your tax, accounting, legal or other advisors as you deem appropriate.
Morgan Stanley is a full-service securities firm engaged in a wide range of financial services including, for example, securities trading and brokerage activities, investment banking, research and analysis, financing and financial advisory services. Morgan Stanley Investment Management is the asset management division of Morgan Stanley.
CRC# 1889570 Expiration Date: 10/1/2018